Select Committee on Trade and Industry Minutes of Evidence


Examination of Witnesses (Questions 307-319)

THE INDIA GROUP

14 MARCH 2006

  Q307 Chairman: Gentlemen, welcome to this evidence session on our inquiry on trade and investment in relation to India. As I think you know, most of us have just returned from a visit to India where we have seen some of your companies in action in the country itself and had an extremely enjoyable, interesting and stimulating visit; I hope that will make for an enjoyable, interesting and stimulating evidence session today as well. Can I ask you to begin by introducing yourselves and perhaps the companies you represent for the record?

  Mr Chatterjee: My name is Sonjoy Chatterjee, I am managing director and CEO of ICICI Bank (UK) Ltd. ICICI Bank is India's largest bank in terms of market capitalisation and second largest in terms of assets. It is listed on the New York Stock Exchange and we set up our 100% subsidiary in the United Kingdom in November 2003; we are now, we believe, the largest Indian bank in the United Kingdom. We have a balance sheet in excess of £1 billion and we have five branches in the United Kingdom. Of notable interest is the fact that in the last year or so we have been advising and funding a majority of the Indian acquisitions in the UK and Europe and, as per the Reuters data, we have a 7% market share there. We also run a very strong internet channel by which we have, I would say, more white Anglo-Saxons as our customers than people of Indian origin, and we have just started expanding into Europe with our first branch in Belgium. I chair The India Group which, as you are aware, is a private sector alliance of the leading Indian companies in the UK and Europe.

  Q308  Chairman: Thank you very much indeed. Who wants to go next?

  Mr Hasan: My name is Anwar Hasan, I am the managing director of Tata Limited; a company that has been in existence from 1907, although actually over the last 100 years we have changed our role. Originally we were in the procurement business because they had a very strict regime of import licensing et cetera back in India, but now the role has changed and I have now taken more a role of group representative in the UK and Europe, and it is through my company that investments into the UK are channelled. Basically we give feedback to companies back in India as to what the lay of the land is over here and it is that role that has now become predominant. For me to earn my keep with the group, I do a lot of procurement, we do a lot of trading and that keeps us a little street-smart as to what is happening.

  Mr Singh: Myself, Sirjiwan Singh, I am the managing director of Wockhardt UK Limited which is a subsidiary of Wockhardt India, and Wockhardt is amongst the top five pharmaceutical companies in India. We are in the business of healthcare management, starting from API manufacturing to formulation manufacturing, moving forward to biotechnology. We were one of the few pharmaceutical companies which, in the very early stages, moved into biotechnology and started the programme of bio-generics in India. We also are strongly present in hospitals; we have got a number of hospitals which are all speciality care hospitals in India, tied up with Harvard Medical International and having a recognition and a partnership with Harvard Medical International, following all the clinical practices of HMI. We do have a lot of patients from the UK also now going over to India for treatment in our hospitals. More than that, I would say, my company grew both organically and inorganically. When we grew inorganically we went through a process of acquisitions and in 1998 it was the first cross-border acquisition that we made in the UK when we bought a company in the UK, the Wallis Laboratory, and after that in 2003 we bought another company in the UK which is CP Pharmaceuticals; these two companies together now are subsidiaries of a company in the UK which is Wockhardt UK. I am pleased to say that we came with the aim of running manufacturing in the UK and we are running here a manufacturing facility with 400 people employed by us today in Wrexham. When we moved westwards everybody was saying how can you sustain manufacturing in the United Kingdom, but we built our business model in such a way that we have been sustaining the business here, carrying out manufacturing, providing products to much more value-added markets like the US, having a facility which manufactures products for the US market. Along with that we are now one of only two providers of animal insulin in the UK, and with one of the competitors moving out of the market in a short while, we will be the key and the only supplier of the animal insulin in the UK market.

  Q309  Chairman: Thank you, that paints a picture of a very varied portfolio as it were among the three of you, which will stand us in very good stead for this session. You know that our concern as a Committee is that Britain, and for that matter India, are perhaps not fully exploiting the historic links between our two countries and the Indian economic miracle which could be to the mutual benefit to our two countries and trade and investment are not as strong as they should be between our countries. That is really the focus of this evidence session, trying to find ways in which we can improve that. My first question to you is really to ask you as business people what you think are the main opportunities for UK companies in India?

  Mr Chatterjee: I guess we will take this question jointly, so I will just give you a few thoughts first and then the other members can join in. To start with it is important to come to the context of what is India today in terms of the opportunities it presents in terms of its very young population, in terms of its GDP growth, in terms of its requirement of services, in terms of its requirement of, I would say, a variety of retail and consumer-oriented goods. To put it into context, that is the first thing that needs to be put on the table, how do you cite India today in terms of all these economic parameters? One way is to assume that this is largely understood and broadly, I would say, the information is well spread out. Although in the few interactions that I have had in platforms where I have been jointly engaged with British businesses, for instance, a platform with the CBI, I have found that businesses here are not so up to date on what is really happening in India. In the first instance I would say that this is one big communication that needs to take place and there are some platforms that have been created like Doing Business with India of UKTI where these kinds of things have come up, but people are still not very sure as to what is really happening if they have some specific elements like the difficulty in setting up legal practices and that does not really cover a wide canvas. To get into specifics, I would imagine that if you look at the UK skill set today, if you look at UK strengths today, specific areas which call for a lot of partnership, a lot of engagement, would be in the area of education, would be in the area of medical science, which would include pharmaceuticals. These are two avenues where straightaway Britain can walk into India and set up a lot of partnerships which would effectively see a surge in terms of how Britain is engaging with India, so there is a clear gap there. Anwar, do you want to add to this?

  Mr Hasan: Invariably India is compared with China and I think in the last four or five years it is China that has really got the biggest piece of the pie, so where India has got four billion FDI in China you will get 40 billion. But there is a certain saturation point that has now been reached in China and more and more companies are now looking at India. Previously, looking at India was vague because people did not get into the nitty-gritty, not actually going there and setting up shop to actually get the feel, to know what the local conditions are like. I do not mind saying this, that perhaps there were a few false dawns originally, things that were supposed to happen did not happen, so people went and what could have been a businesslike trip became a junket and you just come back again. I think this is the last train that is going out to India; if you do not catch this train, you are going to lose out quite a lot in what is going to happen. All you have got to do is go to the Investment Commission—there is a website—and there it will tell you all that is being done, all the investments that are required. I have just taken a brief capture of this and I find it amazing that in the next five to seven years, which is 2012 and beyond, 500 billion is what is required and it is not all required at once, it is over a period of time. Sirjiwan and Sonjoy have talked about pharmaceuticals and healthcare, but there is so much that you can do on real estate, there is so much that you can do on retail, there is so much that can be done on tourism, there is so much that can be done in the infrastructure; I mean, it is limitless. It is a question of where you feel comfortable and, once you feel comfortable with a certain business, it is to focus in that area, set up shop there and please, please, you must take local help because local knowledge is so important—you might have got a feel of this in your trip. If you can seriously get down and stay the course, which is what is most important—like the cricket, in Indian pitches you need patience.

  Q310  Chairman: Do not mention cricket today, please!

  Mr Hasan: You need patience, but if you are patient I can tell you that there are not going to be many more false dawns, there is going to be the pot of gold at the end of the rainbow.

  Mr Chatterjee: I will just come in on this to cite our examples. When ICICI decided to move internationally, Britain was our first overseas office that we set up. Between the time that we set up our office and started the bank, this was a period of almost 16 months, and if I look at our first `wetting our feet situation' in this country, what we saw as the opportunity, what we went to the Financial Services Authority with in terms of what we felt our business proposition should be in this country and what we are doing now, it is completely different. One powerful point that Anwar is making is that businesses must take the first shot in terms of going ahead, setting up a small shop—we now employ 200 people and we have six offices. I sat in one small room in Cannon Street for one year, until I decided okay, this is what we really need to do. That approach and mindset is very important and that is what I think one needs to emphasise.

  Q311  Chairman: Mr Singh, would you like to comment?

  Mr Singh: I always talk to Sonjoy on this matter, what he was really mentioning about coming and sitting in one room. It is the concept of managerial entrepreneurship, that is all the organisation's managers are really going to work in a very entrepreneurial manner and then take these things forward from there. Taking it on from Anwar, I would definitely identify healthcare and medical sciences as an area of collaboration in the future; another area I see is that there is a good amount of biotechnology research being carried out in the United Kingdom, in Scottish universities and various other places. What we need to do is to think of the fusion of future, the fusion of future is going to be innovation of the UK to be combined with cost-effective commercialisation of India. Those are the areas and I definitely see that some of us as companies are doing very well in biotechnology where there can be sound collaboration between the enterprises/universities of the United Kingdom and the companies in India. The biotechnology products are really going to be the products of the future and we are ourselves moving into the area of bio-generics so that in the European Union we are able to provide key drugs. We have already biosynthesised human insulin in India and we are going through a bio-generic programme so that we will be able to offer to the NHS, maybe two or three years down the line, a much more cost-effective human insulin formulation. That is the area where the innovation of the West and the cost-effectiveness of the East can be brought together and that is where British enterprises definitely need to move forward.

  Q312  Chairman: Before I bring in Mr Hoyle I will just pick up two things that you said—not for full answers again but just to seek your agreement. First of all, do you agree with the impression I formed on our visit to India that there is actually a huge hunger among the Indian business community for a better and closer involvement with UK businesses?

  Mr Hasan: There is, yes.

  Mr Singh: Yes.

  Q313  Chairman: You talked in your opening comments, Mr Chatterjee, about perceptions, you talked about a failure of British business properly to understand what is happening in India. India is moving very fast and even those of us who knew India quite well were pleasantly surprised at what we discovered there last week, so I accept that. Do you think there is also a perception problem the other way? I was struck by the number of Indians I spoke to who did not even know we had a car industry left in the United Kingdom and who were surprised at the scale of it, so do you think there are also some problems in the other direction as well?

  Mr Chatterjee: From the Indian perspective, if you see the number of businesses that are trying to get into Britain, I would say that that fact alone should really give the answer that Indians are very up to date in terms of what is happening. There is a situation today where people believe that manufacturing in the British context is on its way out, but what is important to note is that the hunger to have a dialogue, have an engagement, is there today. A lot of them do not know how to go about doing it, and I will cite another example. Let us take an institution like UCL, the largest medical school possibly in Europe.

  Q314  Chairman: UCH?

  Mr Chatterjee: It is called UCL but UCH is one part of it—University College London which has three hospitals under it. It was just a chance lunch meeting that I had with the vice-provost who looks after international matters, and he came up with the fact that they have very little research going on with India and he gave the example of breast cancer where there has been a lot of research that has been done here, but in the Asian context they would like to do a lot more. The desire was that there are Indian companies who we hope will engage with us in this. There are Indian companies like the Apollo Group, which is the largest private sector healthcare group in Asia, like Fortis Healthcare which belongs to the Ranbaxy Group—I did notice that you spent some time with Ranbaxy—and Wockhardt. You noticed when Sirjiwan introduced himself that they have a lot of affiliations with the US and the same applies to the other two, so when I put this to the chairman of Fortis Healthcare he said "That is exactly what I want to do but I do not know how to do it, I have never had a platform on which to engage it." They have now set up a very effective dialogue by which they are now planning to really take this whole research forward. Indians, therefore, at the level at which it matters are very, very conscious of the opportunity but a lot of them have not really got on to taking that forward.

  Chairman: A number of our questions, including Mr Hoyle's, will actually cover some of these areas and then when we get to Roger Berry's questions on HE we will look at some of those issues again. Lindsay Hoyle.

  Q315  Mr Hoyle: Thank you, Chairman. Obviously there is agreement about investment into India, but what about investment into the UK, and your experience of being locked up in a room for 12 months on Cannon Street to build up the decision-making I can understand. Obviously you have already established businesses and bought businesses out, but are you satisfied that the UK is fully open for business? Do you see any barriers that hinder you for trade and investment into the UK? I just wonder because we have certainly heard evidence from witnesses saying when they look to India they feel there are barriers, but do you feel there are any barriers in the UK? Do you think we are fully open, fully liberated?

  Mr Chatterjee: In the first instance my answer would be yes, we believe that the UK does offer a very wide, very open platform in terms of doing business with India here. If one gets into specifics, we have seen a variety of situations—we saw a situation where a member of our group acquired Typhoo Tea which, as you know, is a 100 years old British brand, and because it was a fairly unknown Indian company that was acquiring this brand, for the first few months he had to go through an enormous amount of labour issues, and this was really a situation where everything was settled, put down and formalised but the labour just wanted to take advantage of the situation that this was a fairly unknown entity coming into Britain. To begin to get into specifics—and I keep telling this to the FSA—why should a bank like HSBC have a capital adequacy ratio of 10% and why should ICICI Bank UK, because I am a new bank in this country, have a capital adequacy ratio of 15%? So there are specifics like this which exist, but the reason why I said yes in the first instance is that none of these specifics today are a hindrance to the fact that you can set up a successful business proposition in this country—and a very profitable business proposition—as evidenced by what all of us have done already in this country and by what we have learned. I would say that we as a bank, in our advisory and funding capacity, must be sitting on at least five such transactions of Indian companies acquiring UK companies right now. Just to stray a bit, one corresponding logic that needs to be attached to it is that in some of these platforms that I spoke of regarding the issues about doing business with India, the same spirit should be put into British businesses when they look at India instead of looking at ABC hindrances.

  Mr Singh: I have been here for three years and my experience, since we first went through the acquisition process, first company and then second company, in terms of support from the local government and local agencies—the Welsh Development Agency—they were excellent in dealing with us. The WDA when it deals with the companies which are operating within Wales, including their reach out to India for attracting businesses into the UK, have been plainly very helpful and I much appreciate it. There are very small activities in supporting us—sometimes if we need regional warehousing, how quickly they can react to that and provide us with that support within their infrastructure and I would say the same has been very good—and we enjoy a very close relationship with the WDA, operating in Wrexham. Other than that I would say that definitely when, as managers, we move into another country or we go into cross-border movements, one does initially face some of those apprehensions amongst the people: if an Indian company is acquiring a United Kingdom company how are these guys going to handle it, or how will they handle it in future? Indian managers are fairly well-equipped for leading from the front, they are very well-equipped in that area and they will set examples for leading a company. We have established a very nice infrastructure and we have invested so much in the last four or five years in terms of capital investment into the manufacturing facility that we acquired, it was a very old facility and we replaced everything, which was very welcome. We were therefore building up a feeling that, yes, here is a company that has come over here to stay here, to carry on manufacturing here, and it has worked out very, very well. We did not face any other problems, I would say, although employee-related issues, whether related to TUPE or other things, do come in between sometimes when you are doing a restructuring. All businesses cannot be exactly run as they were being run in the past, one has to do some degree of restructuring, but if it is done with empathy and in a nice manner it is well accepted and we have been successful in doing it.

  Q316  Mr Hoyle: That is fine, it is all about investment, but what about doing trade?

  Mr Chatterjee: Sorry?

  Q317  Mr Hoyle: Obviously everybody's experience is about investment here, taking over companies, but is the UK open to Indian companies for trade?

  Mr Hasan: To talk about the experience that we have had in investment, there has been absolutely no problem. Some of our operating companies had a little bit of difficulty about visas, but that was more time-related, it was not that we did not get the visas, it just took a little bit of time and in the kind of businesses that we are in, IT, time is of the essence. You get so much time to complete a contract, so if your visas to get people across take longer it can be a difficulty, but that has been by and large considerably—

  Chairman: We did hear some continuing complaints actually in India about the visa regime, and we will be addressing that subject. Mick Clapham?

  Q318  Mr Clapham: Sirjiwan, you have just mentioned the help that you got from the Welsh RDA. Do you feel that there is much more that could be done in terms of the way in which we connect business inquiries from India, people wanting to invest here, with the RDAs? If there is more that could be done, how should we do it?

  Mr Chatterjee: The point that Sirjiwan mentioned in terms of what the Welsh Development Agency has done, that itself is really an example of what other agencies like the CBI could do on the reverse side. That is what Indian agencies—which no doubt you have met like CII and FICCI—have done in this country in terms of setting up offices and very actively trying to engage with British businesses, but on the other side should the CBI not have an office let us say in a place like Mumbai, which is really the commercial capital? I think the example Sirjiwan gave of the Welsh Agency, the strides they have taken in their own way, in their own interest, on a much broader platform show an agency which is going to drive this forward, which is very key to this interaction.

  Mr Singh: I must share with you two simple things because irrespective of having any business or not having any business to do with the WDA, every month I get a call from them asking do we need any help or do we have any difficulties anywhere. That is the type of proactive action which the WDA is normally taking with industries which are investing into Wales because Wrexham was going through a phase of many companies closing down and a lot of businesses moving to Thailand and all that. So they have been taking a very proactive role in that.

  Chairman: We will return to some of the representational issues in some later questions if we may, so can we move on to Tony Wright?

  Q319  Mr Wright: One of the things that we saw in India clearly was the massive investment that is going on and obviously the opportunities for a lot of the skilled and a lot of the university graduates, but one of the things that has become quite clear is that there could be in the near future a skills shortage for these Indian companies. Do you consider this is true and, if so, what do you think this would mean for the companies? Some of the evidence that we saw in one of the companies was that there was a board with job opportunities, dozens of job opportunities because people now are selling their labour, there has been this increase in wages and obviously the opportunities are much greater. That could cause a problem in the future, do you agree?

  Mr Chatterjee: No, I do not. I must confess that in terms of the talent that is there across the different levels of talent that one would require whether it be a graduate level talent, whether it be a business school level talent, whether it be a scientific kind of background related talent, across all these segments the amount of talent that is coming out every year, I do not see a situation where talent would fall short. I would see a situation, looking into the future, where it might fall short, and that is if global companies decide that they need to get into India, and you see that in the premier business schools today. I actually was in Bangalore the day before yesterday which houses one of the premier management institutes, the Indian Institute of Management—there are four of these in Ahmadabad, Bangalore, Kolkata and Lucknow—where now one third of the batch is being sourced by global investment banks. I would say the highest salary on campus this year was paid by Barclays Capital, so as an Indian brand 10 years back you could walk in and look at the top 10 persons in the batch but today you are roughly looking at the bottom two-thirds of the batch, but that is a very specific situation where here there are premier business schools and here are the global companies who are getting in and picking up the talent for their New York, London or Singapore offices. If I leave this specific element out, I do not see a skills shortage situation today, but if this trend increases across a wide range of Indian universities and business schools then, yes, it could then lend credence to this situation where there could be a skills shortage.

  Mr Hasan: When you talk in terms of numbers I do not think there is a skills shortage, but if you talk in terms of the quality of the people who were available 10 years ago and the quality that is available now, maybe you do not have that many A-category students available. Business has to also adapt to a situation and I do find that most successful companies have a terrific training department, training programmes, training institutes where they pick up these people and find out where they are in terms of certain skills, then they train them up further to try and hone what is really required by the business.


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2006
Prepared 27 July 2006